Stay updated with breaking news from Study Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
Theralase Provides Update on Phase II Bladder Cancer Study
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in the prevention of stroke events in pa
Investegate announcements from MGC Pharmaceuticals, CogniCann� Phase II Clinical Trial Results